statistiche ricercatore

Continente	#
NA - Nord America	1.104
AS - Asia	499
EU - Europa	404
SA - Sud America	168
OC - Oceania	64
Continente sconosciuto - Info sul continente non disponibili	42
AF - Africa	17
Totale	2.298

Nazione	#
US - Stati Uniti d'America	1.044
SG - Singapore	187
IT - Italia	146
BR - Brasile	132
VN - Vietnam	96
CN - Cina	69
AU - Australia	64
RU - Federazione Russa	52
DE - Germania	42
GB - Regno Unito	33
CA - Canada	27
FI - Finlandia	24
FR - Francia	24
SE - Svezia	18
BD - Bangladesh	17
HK - Hong Kong	17
IN - India	17
MX - Messico	17
KR - Corea	16
AR - Argentina	15
JP - Giappone	13
NL - Olanda	13
ID - Indonesia	11
LV - Lettonia	9
IQ - Iraq	8
EC - Ecuador	7
CO - Colombia	6
ES - Italia	6
JO - Giordania	6
PH - Filippine	6
PK - Pakistan	6
ZA - Sudafrica	6
AT - Austria	5
IE - Irlanda	5
MY - Malesia	5
UA - Ucraina	5
DK - Danimarca	4
LK - Sri Lanka	4
PL - Polonia	4
TH - Thailandia	4
TR - Turchia	4
BE - Belgio	3
CL - Cile	3
GY - Guiana	3
JM - Giamaica	3
KE - Kenya	3
KZ - Kazakistan	3
TT - Trinidad e Tobago	3
BG - Bulgaria	2
HN - Honduras	2
IL - Israele	2
IR - Iran	2
LT - Lituania	2
NG - Nigeria	2
SK - Slovacchia (Repubblica Slovacca)	2
XK - ???statistics.table.value.countryCode.XK???	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
BH - Bahrain	1
BO - Bolivia	1
BS - Bahamas	1
CG - Congo	1
CW - ???statistics.table.value.countryCode.CW???	1
CZ - Repubblica Ceca	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EE - Estonia	1
EG - Egitto	1
ET - Etiopia	1
GD - Grenada	1
GP - Guadalupe	1
GT - Guatemala	1
KW - Kuwait	1
LI - Liechtenstein	1
LU - Lussemburgo	1
MA - Marocco	1
NI - Nicaragua	1
NP - Nepal	1
PA - Panama	1
PR - Porto Rico	1
PT - Portogallo	1
TN - Tunisia	1
UZ - Uzbekistan	1
VE - Venezuela	1
Totale	2.259

Nome	#
Harnessing CRISPR technology for the treatment of cystic fibrosis	388
A highly specific SpCas9 variant is identified by in vivo screening in yeast	361
Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing	224
VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9	197
Combination of lentiviral and genome editing technologies for the treatment of sickle cell disease	173
Functional rescue of F508del-CFTR through revertant mutations introduced by CRISPR base editing	152
Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing	146
Generation of corrected hiPSC clones from a Cornelia de Lange Syndrome (CdLS) patient through CRISPR-Cas-based technology	131
CoCas9 is a compact nuclease from the human microbiome for efficient and precise genome editing	123
Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells	118
Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells	108
Functional restoration of a CFTR splicing mutation through RNA delivery of CRISPR adenine base editor	107
Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression	70
Totale	2.298

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	92	0	0	0	0	3	12	6	17	8	9	17	20
2022/2023	133	24	14	9	18	14	18	2	9	16	0	5	4
2023/2024	114	5	4	5	3	7	16	1	6	1	9	26	31
2024/2025	350	30	11	22	46	32	23	4	20	31	49	39	43
2025/2026	1.072	79	118	125	190	130	72	99	31	83	64	47	34
2026/2027	300	48	44	75	133	0	0	0	0	0	0	0	0
Totale													2.298